Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities
Manzar Alam, Md. Meraj Ansari, Saba Noor, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 1022-1037
Closed Access | Times Cited: 15

Showing 15 citing articles:

Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114452-114452
Open Access | Times Cited: 22
Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits
Manzar Alam, Summya Rashid, Kisa Fatima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114710-114710
Open Access | Times Cited: 21
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease
Mohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma
Gulam Mustafa Hasan, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal, et al.
ACS Omega (2023) Vol. 8, Iss. 30, pp. 26685-26698
Open Access | Times Cited: 15
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 394-408
Closed Access | Times Cited: 25
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 8
ATG4B antagonizes antiviral immunity by GABARAP-directed autophagic degradation of TBK1
Weihong Xie, Chenqiu Zhang, Zheyu Wang, et al.
Autophagy (2023) Vol. 19, Iss. 11, pp. 2853-2868
Closed Access | Times Cited: 7
Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease
Léa Bedja-Iacona, Élodie Richard, Sylviane Marouillat, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8664-8664
Open Access | Times Cited: 1
Frustration analysis of TBK1 missense mutations reported in ALS/FTD and cancer patients
Fatima Khatoon, Vijay Kumar, Farah Anjum, et al.
3 Biotech (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 5
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
Mariaserena Giliberto, Leonardo Miranda Santana, Toril Holien, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Ubiquitin specific protease 38 aggravates pathological cardiac remodeling by stabilizing phospho-TBK1
Zheng Xiao, Chang Dai, Tingting Yu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1815-1832
Open Access
Crosstalk and Prospects of TBK1 in Inflammation
Huan Liu, Qihuan Sheng, Juhua Dan, et al.
Immunological Investigations (2024) Vol. 53, Iss. 8, pp. 1205-1233
Closed Access
Amlexanox targeted inhibition of TBK1 regulates immune cell function to exacerbate DSS-induced inflammatory bowel disease
Lu Hui, Meng-ke Huang, Qingkai Dai, et al.
Clinical & Experimental Immunology (2024)
Open Access
Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma
W J Shih, Han‐Li Huang, Wei‐Chun HuangFu, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137296-137296
Closed Access
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection
Ifeanyi Jude Ezeonwumelu, Edurne García-Vidal, Eva Riveira‐Muñoz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15000-15000
Open Access
Page 1

Scroll to top